A Two-Arm Phase II Chemoprevention Trial in Adenomatous Polyposis Coli Patients

Trial Profile

A Two-Arm Phase II Chemoprevention Trial in Adenomatous Polyposis Coli Patients

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2016

At a glance

  • Drugs Celecoxib (Primary) ; Eflornithine
  • Indications Colorectal cancer; Familial adenomatous polyposis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jun 2012 Planned End Date changed from 1 Oct 2012 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 22 May 2012 Results presented at Digestive Disease Week 2012.
    • 02 Jun 2011 Planned end date changed from 1 Oct 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top